Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review

Cancer Treat Rev. 2022 Sep:109:102427. doi: 10.1016/j.ctrv.2022.102427. Epub 2022 Jun 21.

Authors

Douglas W Blayney¹, Lee Schwartzberg²

Affiliations

¹ Stanford Cancer Institute, Stanford, CA, United States. Electronic address: [email protected].
² Renown Institute for Cancer, University of Nevada, Reno, Reno, NV, United States.

PMID: 35785754
DOI: 10.1016/j.ctrv.2022.102427

No abstract available

Keywords: Chemotherapy-induced neutropenia; Efbemalenograstim alpha; Eflapegrastim; G-CSF; Plinablin; Trilaciclib.

Publication types

Review

MeSH terms

Antineoplastic Agents* / adverse effects
Granulocyte Colony-Stimulating Factor
Humans
Neutropenia* / chemically induced
Neutropenia* / prevention & control

Substances

Antineoplastic Agents
Granulocyte Colony-Stimulating Factor